Search For "controller"
Proceedings initiated against Gautam Gambhir, AAP MLAs for stocking of med
Updated : 4 years, 8 months ago IST
New Delhi [India], July 17 (ANI): Delhi's Drug Controller Department told the Delhi High Court that it has initiated proceedings against Bharatiya Janata Party leader and Member of Parliament Gautam Gambhir's foundation, and Aam Aadmi Party legislators Praveen Kumar and Imran Hussain for
Read More
DCGI examining Zydus Cadila's COVID vaccine for children, says Dr VK Paul
Updated : 4 years, 8 months ago IST
New Delhi [India], July 16 (ANI): Drugs Controller General of India (DCGI) is examining pharmaceutical major Zydus Cadila's COVID-19 vaccine for children, said Dr VK Paul, Member-Health, Niti Aayog on Friday.
Read More
Pfizer, Johnson and Johnson yet to apply for license of COVID-19 vaccines
Updated : 4 years, 8 months ago IST
New Delhi [India], July 15 (ANI): The Drug Controller General of India (DCGI) has urged Pfizer, Johnson and Johnson twice in writing to apply for emergency use authorisation for their COVID-19 vaccine so that application is processed well in time but pharma companies have not applied for
Read More
Emergency approval for Zydus Cadila to take few more days, say sources
Updated : 4 years, 8 months ago IST
New Delhi [India], July 12 (ANI): India's drug regulator Drugs Controller General of India (DCGI) will consider giving emergency use authorisation (EUA) to Zydus Cadila for its COVID-19 vaccine ZyCoV-D in a few more days, sources told ANI.
Read More
Zydus Cadila seeks nod for its COVID-19 vaccine ZyCoV-D, aims to produce 1
Updated : 4 years, 8 months ago IST
New Delhi [India], July 1 (ANI): The pharmaceutical firm Zydus Cadila on Thursday informed that it has applied for emergency use authorisation (EUA) from the Drug Controller General of India (DCGI) for its DNA vaccine ZyCoV-D against coronavirus disease and stated that they expect to produce
Read More
Zydus Cadila seeks emergency use authorisation for ZyCoV-D COVID-19 vaccin
Updated : 4 years, 8 months ago IST
New Delhi [India], July 1 (ANI): Pharmaceutical major Zydus Cadila on Thursday applied for Emergency Use Authorisation (EUA) seeking approval from the Drugs Controller General of India (DCGI) for the launch of their ZyCoV-D vaccine for 12 years and above, sources said .
Read More
Johnson & Johnson won't be conducting COVID-19 vaccine trials in India
Updated : 4 years, 8 months ago IST
New Delhi [India], June 29 (ANI): Johnson & Johnson will not be conducting local trials in India for its single-dose COVID-19 vaccine, a spokesperson of the US-based pharma company said on Tuesday.
Read More
Pfizer in 'final stages' of getting approval for COVID-19 vaccine in India
Updated : 4 years, 8 months ago IST
New Delhi [India], June 22 (ANI): US pharmaceutical giant Pfizer on Tuesday said it is in the "final stages" of getting approval for its COVID-19 vaccine in India.
Read More
DCGI likely to approve phase 3 trial data of Covaxin on Tuesday
Updated : 4 years, 8 months ago IST
New Delhi [India], June 22 (ANI): The Drugs Controller General of India (DCGI) is likely to approve Phase III trial data of Covaxin on Tuesday, sources said.
Read More
Bharat Biotech has submitted Covaxin's Phase III trial data to DCGI: Govt
Updated : 4 years, 8 months ago IST
New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller General of India (DCGI) over the weekend, according to government sources.
Read More
DCGI grants SII permission to manufacture Sputnik V for specific regulator
Updated : 4 years, 9 months ago IST
New Delhi [India], June 4 (ANI): The Drug Controller General of India (DCGI) on Friday granted the approval to the Serum Institute of India (SII) for the initial manufacture of the Russian COVID-19 vaccine Sputnik V for testing, examination, and analysis purposes with certain conditions at i
Read More
Children can't be vaccinated currently, trials on below 18 underway: Centr
Updated : 4 years, 9 months ago IST
New Delhi [India], June 4 (ANI): Centre through an affidavit on Friday informed the Delhi High Court that on May 12, 2021, the Drug Controller General of India (DCGI) has permitted Bharat Biotech to conduct clinical trials on healthy volunteers between 2 years to 18 years of age for its vacc
Read More